Viral Myocarditis-Incidence, Diagnosis and Management. 2020

Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
University of Minnesota, Department of Anesthesia, Minneapolis, MN.

Viral myocarditis has an incidence rate of 10 to 22 per 100,000 individuals. The presentation pattern of viral myocarditis can range from nonspecific symptoms of fatigue and shortness of breath to more aggressive symptoms that mimic acute coronary syndrome. After the initial acute phase presentation of viral myocarditis, the virus may be cleared, resulting in full clinical recovery; the viral infection may persist; or the viral infection may lead to a persistent autoimmune-mediated inflammatory process with continuing symptoms of heart failure. As a result of these 3 possibilities, the diagnosis, prognosis, and treatment of viral myocarditis can be extremely unpredictable and challenging for the clinician. Herein, the incidence, etiology, definition and classification, clinical manifestation, diagnosis, pathogenesis, prognosis, and treatment of viral myocarditis are reviewed, and how acute clinical care teams might differentiate between viral myocarditis and other acute cardiac conditions is discussed.

UI MeSH Term Description Entries
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014777 Virus Diseases A general term for diseases caused by viruses. Viral Diseases,Viral Infections,Virus Infections,Disease, Viral,Disease, Virus,Diseases, Viral,Diseases, Virus,Infection, Viral,Infection, Virus,Infections, Viral,Infections, Virus,Viral Disease,Viral Infection,Virus Disease,Virus Infection
D015994 Incidence The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases in the population at a given time. Attack Rate,Cumulative Incidence,Incidence Proportion,Incidence Rate,Person-time Rate,Secondary Attack Rate,Attack Rate, Secondary,Attack Rates,Cumulative Incidences,Incidence Proportions,Incidence Rates,Incidence, Cumulative,Incidences,Person time Rate,Person-time Rates,Proportion, Incidence,Rate, Attack,Rate, Incidence,Rate, Person-time,Rate, Secondary Attack,Secondary Attack Rates
D016732 Parvovirus B19, Human The type species of ERYTHROVIRUS and the etiological agent of ERYTHEMA INFECTIOSUM, a disease most commonly seen in school-age children. B19 virus,Human Parvovirus B19,Parvovirus B19,B19 viruses,B19, Parvovirus,Parvovirus B19s

Related Publications

Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
January 1997, Advances in pediatrics,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
December 2007, Current treatment options in cardiovascular medicine,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
July 2009, Drugs,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
January 2013, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
November 1975, Der Internist,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
November 2009, Mayo Clinic proceedings,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
March 1989, American heart journal,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
January 2022, Frontiers in cardiovascular medicine,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
March 2001, Current opinion in cardiology,
Megan Olejniczak, and Matthew Schwartz, and Elizabeth Webber, and Andrew Shaffer, and Tjorvi E Perry
March 1984, Der Internist,
Copied contents to your clipboard!